Article Details

Why AstraZeneca Is Buying CinCor Pharma For $1.8 Billion (AZN) (CINC) - Pulse 2.0

Retrieved on: 2023-01-09 20:11:48

Tags for this article:

Click the tags to see associated articles and topics

Why AstraZeneca Is Buying CinCor Pharma For $1.8 Billion (AZN) (CINC) - Pulse 2.0. View article details on HISWAI: https://pulse2.com/why-astrazeneca-is-buying-cincor-pharma-for-1-8-billion-azn-cinc/

Excerpt

This deal would bolster AstraZeneca's portfolio of heart and kidney drugs. CinCor's experimental therapy baxdrostat has been a strong selling point ...

Article found on: pulse2.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up